Nitrosamines risk assessment: step 1

[@surimummadi]

Lovely presentation 😊

[@yomudon2]

It is very fun. I like it. I'm looking forward to the next video.

[@pravinjaiswal7500]

Excellent video.. Congratulations Fernenda

[@FernandaWaechter]

Thank you Pravin!

[@amitgupta-yr5pl]

Excellent content,thanks for sharing.

[@bhavaniguttula2713]

Good information

[@socialstigmatist6268]

This was excellent, thanks for sharing.

[@reddysivadesireddy1822]

Thanks for sharing knowledge.

[@durgarajkondempudi9335]

Really Fabulous💝

[@FernandaWaechter]

Thanks dear :)

[@eniksonpontes3178]

I really appreciate it! Fernanda, thank you

[@jkgupta3334]

Please upload more vedios NDSRI

[@joaonardo206]

Very good video.. Congrats!

[@durgarajkondempudi9335]

Fabulous explanation Farnanda 💝

[@FernandaWaechter]

Thank you!! :)

[@harshalchaudhari4617]

Nice information love u mam😂

[@modernmogli5155]

👍

[@playlistajsy4486]

Please give link of complete info about nitrosamine impurities, residual solvants, elemental impurities, related substancea etc etc

[@krupa.b8153]

Do we need to combine general nitrosamines and NDSRIs while setting specification limit ( considering most potent one) .please suggest

[@FernandaWaechter]

@@krupa.b8153 Hi Krupa, yes - if more nitrosamines are actually present and need to be controlled in the specification, then you should have a limit for total nitrosamines which may consider the most potent one and NDSRIs should also be considered for this. Unless their mechanism of mutagenicity is different e.g. category 4 or 5 based on CPCA, in which case they fall outside the cohort of concern. In this case I would recommend to confirm with the health authority but I would expect that the NDSRI doesn’t need to be part of that sum for total nitrosamines.

[@Jitendersingh-gn8bm]

Will you please provide a PowerPoint presentation on this topic

[@durgarajkondempudi9335]

Really Fabulous💝

[@FernandaWaechter]

Durgaraj Kondempudi thank you dear!!